October 03, 2018
Rose
Memorial Sloan Kettering Cancer Center President, Dr. Craig Thompson, announced that he will resign from the boards of Merck and Charles River Laboratories. Merck is the maker of the blockbuster cancer treatment Keytruda. Memorial Sloan Kettering Cancer Center has been thrust under the microscope recently over controversy involving top officials' financial conflicts of interest.
from Kaiser Health News https://ift.tt/2y9Z43a
October 03, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
California’s Tax On Millionaires Yields Big Benefits For People With Mental Illness, Study Finds- After Trying Nearly Everything Else To Protect Drug Profits, Pharma Tries Actually Cutting Prices
- Opioid Maker Funds Efforts To Fight Addiction: Is It ‘Blood Money’ Or Charity?
- Perspectives: The Poster Child For High Drug Prices Is Getting Locked Up, But That Won’t End Cost Controversy
- First Edition: March 14, 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment